Expression and clinical significance of serum galactose lectin-2 and transforming growth factor-β2 in patients with atrial fibrillation.

MLA

Yang Hai-chen, et al. “Expression and Clinical Significance of Serum Galactose Lectin-2 and Transforming Growth Factor-Β2 in Patients with Atrial Fibrillation.” Journal of Hainan Medical University, vol. 28, no. 17, Nov. 2022, pp. 26–31. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=159837002&authtype=sso&custid=ns315887.

APA

Yang Hai-chen, Geng Jia-yi, Li Hao-yu, Xu Ning, Liu Chen-yang, Kang Pin-fang, & Zhang Heng. (2022). Expression and clinical significance of serum galactose lectin-2 and transforming growth factor-β2 in patients with atrial fibrillation. Journal of Hainan Medical University, 28(17), 26–31.

Chicago

Yang Hai-chen, Geng Jia-yi, Li Hao-yu, Xu Ning, Liu Chen-yang, Kang Pin-fang, and Zhang Heng. 2022. “Expression and Clinical Significance of Serum Galactose Lectin-2 and Transforming Growth Factor-Β2 in Patients with Atrial Fibrillation.” Journal of Hainan Medical University 28 (17): 26–31. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=159837002&authtype=sso&custid=ns315887.